G61.81

Clinical Causes: Autoimmune response where the immune system attacks peripheral nerve myelin Genetic predisposition in some cases Infections that trigger immune reactions Certain underlying conditions such as diabetes or lymphoma Environmental factors that may contribute to immune dysregulation

Key Symptoms: Progressive weakness in the arms and legs Reduced or lost reflexes Sensory disturbances like numbness, tingling, or burning sensations Difficulty with coordination and balance Unusual fatigue and muscle wasting in advanced stages Pain or discomfort in affected limbs Possible cranial nerve involvement leading to facial weakness or difficulties

Diagnosis Path: Diagnosis of CIDP typically involves a combination of clinical assessment and specialized tests. Healthcare providers may perform neurological examinations to evaluate muscle strength, reflexes, and sensory responses. Diagnostic tests may include nerve conduction studies and electromyography (EMG) to assess nerve signal speed and muscle response. Spinal fluid analysis, often via a lumbar puncture, can reveal elevated protein levels characteristic of CIDP. Imaging studies such as MRI may be used to rule out other conditions. A thorough medical history and physical examination are essential to differentiate CIDP from other neurological disorders.

Treatment Protocols: Managing CIDP usually involves therapies aimed at suppressing the immune response and reducing inflammation. Common treatments include intravenous immunoglobulin (IVIG), corticosteroids, and plasmapheresis (plasma exchange). Physical therapy and occupational therapy can help maintain muscle strength and improve mobility. In some cases, immunosuppressive drugs might be prescribed. Early diagnosis and intervention are critical to prevent nerve damage and preserve function. Regular monitoring and adjustments in treatment strategies are often necessary to optimize outcomes and manage symptoms effectively.